ancitabine hydrochloride - antineoplastic agent for lymphatic leukemia and sinus acceleration

REF #: 3199690
Procurenet
Short description

ancitabine hydrochloride is an antineoplastic agent used for the treatment of lymphatic leukemia and sinus acceleration. it is also available as part of library of pharmacologically active compounds (lopaca8598).

  • ancitabine hydrochloride
  • 2,2′-anhydro-(1-оі-d-arabinofuranosyl)cytosine
  • cyclo-c
  • cyclocytidine
  • chemical formula: 10212-25-6
$0
Quantity :
  • Procurenet Team Tshim Sha Tsui
    Hong Kong Hong Kong 3 years
Delivery options
  • 7 Days Return Back Policy
  • 2 Days Cancellation Policy
  • Ship Only
Description

ancitabine hydrochloride is an antineoplastic agent used for the treatment of lymphatic leukemia and sinus acceleration. it is available as a white crystalline powder that is soluble in water. this potent antineoplastic agent belongs to the class of nucleoside analogs and has shown promising results in the treatment of various forms of cancer.

the mechanism of action of ancitabine hydrochloride involves its incorporation into the dna or rna strands of cancer cells during replication. this disrupts their growth and division, ultimately leading to their death. by inhibiting the enzyme ribonucleotide reductase, the compound interferes with the synthesis of dna and rna, impeding the cancer cells' ability to replicate and produce new molecules.

ancitabine hydrochloride exhibits several key features and characteristics, which include:

  • appearance: white crystalline powder
  • solubility: soluble in water
  • molecular weight: 149.59 g/mol
  • chemical formula: c9h12n3o4·hcl
  • storage conditions: store in a cool and dry place, away from direct sunlight
  • stability: stable under recommended storage conditions
  • handling precautions: use appropriate protective clothing and gloves when handling ancitabine hydrochloride

ancitabine hydrochloride has demonstrated efficacy in the treatment of lymphatic leukemia and sinus acceleration. furthermore, its use in combination therapy with other chemotherapeutic agents has shown promising results, as it enhances the cytotoxic effects of other drugs, leading to increased cell death in cancer cells.

with its availability as part of library of pharmacologically active compounds (lopaca8598), researchers and scientists can easily access ancitabine hydrochloride for research and development purposes. this comprehensive library offers a wide range of bioactive compounds for various applications, including drug discovery and development.

in conclusion, ancitabine hydrochloride is a potent antineoplastic agent used for the treatment of lymphatic leukemia and sinus acceleration. its mechanism of action involves disrupting the synthesis of dna and rna in cancer cells, ultimately leading to their death. this compound exhibits key features such as its white crystalline powder form, solubility in water, and stability under recommended storage conditions. ancitabine hydrochloride has shown efficacy in combination therapy with other antineoplastic agents and is readily accessible for research purposes through library of pharmacologically active compounds.

All categories
Filters